Related Experiment Video
Updated: Oct 18, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma
Fuchuan Xie1, Wei Xiao1, Yunming Tian1
1Department of Radiation Oncology, Huizhou Municipal Central Hospital, Guangdong, China.
Abstract:
MicroRNAs (miRNAs) are revealed to participate in the progression of multiple malignancies, including nasopharyngeal carcinoma (NPC). This work is intended to decipher the function of microRNA-195-3p (miR-195-3p) in regulating the radiosensitivity of NPC cells and its mechanism. MiR-195-3p and cyclin-dependent kinase 1 (CDK1) expressions were detected in NPC tissues and cells using qRT-PCR and Western blot, respectively. Moreover, radiation-resistant cell lines were induced by continuous irradiation with different doses. Furthermore, the CCK-8 experiment, colony formation assay and flow cytometry were utilized to examine the growth, apoptosis and cell cycle of radioresistant cells. Bioinformatics prediction and dual-luciferase reporter gene assay were applied to prove the targeting relationship between miR-195-3p and CDK1 mRNA 3'UTR. The data showed that miR-195-3p was remarkably down-modulated in NPC tissues and was associated with increased tumor grade, lymph node metastasis and clinical stage of the patients. MiR-195-3p expression was significantly down-modulated in radiation-resistant NPC tissues and NPC cell lines relative to radiation-sensitive NPC tissues and human nasopharyngeal epithelial cells, while CDK1 expression was notably up-modulated. MiR-195-3p overexpression inhibited the growth of NPC cells, decreased radioresistance, promoted apoptosis, and impeded the cell cycle progression. CDK1 was a target gene of miR-195-3p, and CDK1 overexpression counteracted the effects of miR-195-3p on NPC cell growth, apoptosis, cell cycle progression and radiosensitivity. In summary, miR-195-3p improves the radiosensitivity of NPC cells by targeting and regulating CDK1.
Insights
MicroRNA-195-3p enhances radiosensitivity in nasopharyngeal carcinoma (NPC) by targeting CDK1. Lower miR-195-3p levels correlate with advanced NPC, while its overexpression inhibits tumor growth and improves radiation response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play a role in cancer progression, including nasopharyngeal carcinoma (NPC).
- Understanding miRNA regulation of radiosensitivity is crucial for improving NPC treatment outcomes.
Purpose of the Study:
- To investigate the function of microRNA-195-3p (miR-195-3p) in NPC radiosensitivity.
- To elucidate the underlying molecular mechanism involving cyclin-dependent kinase 1 (CDK1).
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blot to assess miR-195-3p and CDK1 expression.
- Cell culture models to induce radiation resistance and evaluate cell growth, apoptosis, and cell cycle.
- Bioinformatics prediction and dual-luciferase reporter assays to confirm the miR-195-3p/CDK1 interaction.
Main Results:
- miR-195-3p was downregulated in NPC tissues and associated with advanced tumor characteristics.
- Radiation-resistant NPC cells exhibited lower miR-195-3p and higher CDK1 expression.
- miR-195-3p overexpression reduced NPC cell growth, enhanced apoptosis, arrested the cell cycle, and increased radiosensitivity.
- CDK1 was validated as a direct target of miR-195-3p, and its overexpression reversed miR-195-3p's effects.
Conclusions:
- miR-195-3p functions as a tumor suppressor in NPC by targeting CDK1.
- Upregulating miR-195-3p can enhance the radiosensitivity of NPC cells, offering a potential therapeutic strategy.
Related Concept Videos
MicroRNAs
Inhibition of Cdk Activity
Abnormal Proliferation
Experimental RNAi
Negative Regulator Molecules

